189 related articles for article (PubMed ID: 37085672)
1. Telomerase deficiency and dysfunctional telomeres in the lung tumor microenvironment impair tumor progression in NSCLC mouse models and patient-derived xenografts.
Piñeiro-Hermida S; Bosso G; Sánchez-Vázquez R; Martínez P; Blasco MA
Cell Death Differ; 2023 Jun; 30(6):1585-1600. PubMed ID: 37085672
[TBL] [Abstract][Full Text] [Related]
2. Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC.
Liu W; Yin Y; Wang J; Shi B; Zhang L; Qian D; Li C; Zhang H; Wang S; Zhu J; Gao L; Zhang Q; Jia B; Hao L; Wang C; Zhang B
Oncotarget; 2017 Jan; 8(1):179-190. PubMed ID: 27329725
[TBL] [Abstract][Full Text] [Related]
3. Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC).
Storti CB; de Oliveira RA; de Carvalho M; Hasimoto EN; Cataneo DC; Cataneo AJM; De Faveri J; Vasconcelos EJR; Dos Reis PP; Cano MIN
Exp Mol Pathol; 2020 Feb; 112():104354. PubMed ID: 31837325
[TBL] [Abstract][Full Text] [Related]
4. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
5. Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2'-deoxyguanosine.
Mender I; Gryaznov S; Dikmen ZG; Wright WE; Shay JW
Cancer Discov; 2015 Jan; 5(1):82-95. PubMed ID: 25516420
[TBL] [Abstract][Full Text] [Related]
6. TPP1 OB-fold domain protein suppresses cell proliferation and induces cell apoptosis by inhibiting telomerase recruitment to telomeres in human lung cancer cells.
Zhu J; Liu W; Chen C; Zhang H; Yue D; Li C; Zhang L; Gao L; Huo Y; Liu C; Giaccone G; Zhang B; Wang C
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1509-1519. PubMed ID: 31016380
[TBL] [Abstract][Full Text] [Related]
7. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
8. Silencing PinX1 enhances radiosensitivity and antitumor-immunity of radiotherapy in non-small cell lung cancer.
Qiu J; Xia Y; Bao Y; Cheng J; Liu L; Qian D
J Transl Med; 2024 Mar; 22(1):228. PubMed ID: 38431575
[TBL] [Abstract][Full Text] [Related]
9. Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
Frink RE; Peyton M; Schiller JH; Gazdar AF; Shay JW; Minna JD
Oncotarget; 2016 May; 7(22):31639-51. PubMed ID: 27192120
[TBL] [Abstract][Full Text] [Related]
10. Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation.
Yuan P; Huang S; Bao FC; Cao JL; Sheng HX; Shi L; Lv W; Hu J
Eur J Cancer; 2019 Oct; 120():10-19. PubMed ID: 31446212
[TBL] [Abstract][Full Text] [Related]
11. Dysfunctional telomeres promote genomic instability and metastasis in the absence of telomerase activity in oncogene induced mammary cancer.
Bojovic B; Crowe DL
Mol Carcinog; 2013 Feb; 52(2):103-17. PubMed ID: 22086874
[TBL] [Abstract][Full Text] [Related]
12. Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.
Sengupta S; Sobo M; Lee K; Senthil Kumar S; White AR; Mender I; Fuller C; Chow LML; Fouladi M; Shay JW; Drissi R
Mol Cancer Ther; 2018 Jul; 17(7):1504-1514. PubMed ID: 29654065
[TBL] [Abstract][Full Text] [Related]
13. Short and dysfunctional telomeres protect from allergen-induced airway inflammation.
Piñeiro-Hermida S; Martínez P; Blasco MA
Aging Cell; 2021 May; 20(5):e13352. PubMed ID: 33942458
[TBL] [Abstract][Full Text] [Related]
14. IGF1R acts as a cancer-promoting factor in the tumor microenvironment facilitating lung metastasis implantation and progression.
Alfaro-Arnedo E; López IP; Piñeiro-Hermida S; Canalejo M; Gotera C; Sola JJ; Roncero A; Peces-Barba G; Ruíz-Martínez C; Pichel JG
Oncogene; 2022 Jul; 41(28):3625-3639. PubMed ID: 35688943
[TBL] [Abstract][Full Text] [Related]
15. Evodiamine suppresses non-small cell lung cancer by elevating CD8
Jiang ZB; Huang JM; Xie YJ; Zhang YZ; Chang C; Lai HL; Wang W; Yao XJ; Fan XX; Wu QB; Xie C; Wang MF; Leung EL
J Exp Clin Cancer Res; 2020 Nov; 39(1):249. PubMed ID: 33208183
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Significance of TERT Locus Polymorphism (rs36115365) in Surgically Resected Non-Small Cell Lung Cancer.
Lee DH; Jung SJ; Park WJ; Heo YR; Lee JH
Ann Clin Lab Sci; 2020 Sep; 50(5):645-649. PubMed ID: 33067210
[TBL] [Abstract][Full Text] [Related]
17. Real-time RT-PCR quantification of human telomerase reverse transcriptase splice variants in tumor cell lines and non-small cell lung cancer.
Mavrogiannou E; Strati A; Stathopoulou A; Tsaroucha EG; Kaklamanis L; Lianidou ES
Clin Chem; 2007 Jan; 53(1):53-61. PubMed ID: 17130181
[TBL] [Abstract][Full Text] [Related]
18. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
19. Tumorigenic effect of
Yang L; Li N; Wang M; Zhang YH; Yan LD; Zhou W; Yu ZQ; Peng XC; Cai J
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278503
[TBL] [Abstract][Full Text] [Related]
20. Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.
Ningarhari M; Caruso S; Hirsch TZ; Bayard Q; Franconi A; Védie AL; Noblet B; Blanc JF; Amaddeo G; Ganne N; Ziol M; Paradis V; Guettier C; Calderaro J; Morcrette G; Kim Y; MacLeod AR; Nault JC; Rebouissou S; Zucman-Rossi J
J Hepatol; 2021 May; 74(5):1155-1166. PubMed ID: 33338512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
